Core Viewpoint - The company reported a significant revenue increase in 1H2025, driven by production and sales growth from new bases in Hubei and Guangxi, despite a decline in net profit due to pricing pressures on high-value products [1][2]. Financial Performance - In 1H2025, the company achieved revenue of 5.99 billion yuan, a year-on-year increase of 30.1%, while net profit attributable to shareholders was 470 million yuan, a decrease of 13.8% [1]. - For 1Q2025, revenue was 2.99 billion yuan, reflecting a year-on-year growth of 35.4%, with net profit at 240 million yuan [1]. - The production of specialty pulp paper reached 1.108 million tons in 1H2025, up 98.6% year-on-year, and sales volume was 833,000 tons, an increase of 62.3% [1]. Product Performance - In 1H2025, the food and medical consumer category achieved sales of 147,000 tons, a year-on-year increase of 35.7%, while the daily consumer series saw a sales increase of 24.9% [1]. - The average price of specialty pulp paper in 1Q2025 and 2Q2025 was approximately 7,480 yuan and 6,920 yuan per ton, respectively, with a quarter-on-quarter decrease of about 560 yuan in 2Q2025 [2]. Profitability and Cost Structure - The gross margin for 1H2025 was 13.7%, down 4.0 percentage points year-on-year, with 2Q2025 gross margin at 12.8%, a decline of 4.6 percentage points year-on-year and 1.8 percentage points quarter-on-quarter [1][2]. - The company’s expense ratio for 1H2025 was 6.2%, an increase of 0.4 percentage points year-on-year, with financial expenses slightly rising [2]. Future Outlook - The company anticipates a recovery in profitability in the second half of the year, as the Guangxi base has achieved stable profitability, while the Hubei base is still ramping up production [2]. - The company maintains a "buy" rating, expecting improved profitability despite competitive pressures and pricing declines in some products [2].